(Q37732504)

22 August 2017

1 reference

title

Chemotherapy of adult acute lymphoblastic leukaemia (English)

1 reference

22 August 2017

1 reference

1 reference

Stryckmans P

1

1 reference

PubMed ID

2039854

22 August 2017

Debusscher L

series ordinal

2

1 reference

22 August 2017

1 January 1991

1 reference

Best Practice and Research: Clinical Haematology

22 August 2017

1 reference

22 August 2017

4

1 reference

22 August 2017

1

1 reference

22 August 2017

115-130

1 reference

Philadelphia chromosome (Ph1)-positive acute lymphoblastic leukemia (ALL) is resistant to effective therapy for Ph1-negative ALL.

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Improved survival from acute lymphoblastic leukemia in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Four-agent induction and intensive asparaginase therapy for treatment of childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Combination chemotherapy and radiotherapy for acute lymphocytic leukemia in adults: Results of CALGB protocol 7113

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Recent Advances in the Biology and Treatment of Acute Lymphoblastic Leukemia in Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Treatment of adult acute lymphoblastic leukaemia using an intensive chemotherapy protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Combination chemotherapy for acute lymphoblastic leukaemia in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Effective treatment of lymphomas of Burkitt's type and B-ALL in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

High-dose methotrexate for the remission induction of refractory adult acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Adriamycin in combination chemotherapy of adult acute lymphoblastic leukemia: A southwest oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Effective multidrug, multimodality consolidation therapy of adult acute lymphocytic leukemia: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

Combination chemotherapy for haematological relapse in adult acute lymphoblastic leukaemia (ALL)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980287-2

7 January 2021

10.1016/S0950-3536(05)80287-2

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

2039854